Mediwound Stock In The News

MDWD Stock  USD 17.75  0.24  1.33%   
Our overall analysis of Mediwound's news coverage and content from conventional and social sources shows investors' bearish mood towards Mediwound. The specific impact of Mediwound news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Mediwound's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Mediwound headlines in addition to utilizing other, more conventional financial analysis modules. Check out Mediwound Backtesting and Mediwound Hype Analysis.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.

Mediwound Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
MediWound Reports Third Quarter 2023 Financial Results and Provides Company Update
https://www.globenewswire.com/news-release/2023/11/21/2783933/30505/en/MediWound-Reports-Third-Quarter-2023-Financial-Results-and-Provides-Company-Update.html
 Neutral
Macroaxis News: globenewswire.com
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
https://www.globenewswire.com/news-release/2023/11/21/2783924/30505/en/MediWound-Announces-Appointment-of-Shmulik-Hess-Ph-D-as-Chief-Operating-Officer-and-Chief-Commercial-Officer.html
 Bullish
Macroaxis News: globenewswire.com
MediWound to Report Third Quarter 2023 Financial Results
https://www.globenewswire.com/news-release/2023/11/14/2780053/30505/en/MediWound-to-Report-Third-Quarter-2023-Financial-Results.html
 Bullish
Macroaxis News: globenewswire.com
MediWound Receives Positive CHMP Opinion Recommending Approval for NexoBrid® to Treat Pediatric Patients
https://www.globenewswire.com/news-release/2023/11/13/2778887/30505/en/MediWound-Receives-Positive-CHMP-Opinion-Recommending-Approval-for-NexoBrid-to-Treat-Pediatric-Patients.html
 Bullish
Macroaxis News: globenewswire.com
MediWound Announces a Collaboration with PolyMedics Innovations (PMI) for NexoBrid® Distribution in Europe
https://www.globenewswire.com/news-release/2023/11/08/2776066/30505/en/MediWound-Announces-a-Collaboration-with-PolyMedics-Innovations-PMI-for-NexoBrid-Distribution-in-Europe.html
 Bullish
Yahoo News
MDXG: Xenografts and Synthetics Options for Expansion
https://finance.yahoo.com/news/mdxg-xenografts-synthetics-options-expansion-105000374.html
 Bullish
Macroaxis News: globenewswire.com
MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
https://www.globenewswire.com/news-release/2023/10/11/2758146/30505/en/MediWound-Announces-Collaboration-with-3M-on-EscharEx-Phase-III-Study.html
 Bullish
Yahoo News
MediWound Announces Collaboration with 3M on EscharEx® Phase III Study
https://finance.yahoo.com/news/mediwound-announces-collaboration-3m-escharex-100000502.html
 Bullish
Macroaxis News: globenewswire.com
MediWound Deploys NexoBrid® for Emergency Supply
https://www.globenewswire.com/news-release/2023/10/09/2756602/30505/en/MediWound-Deploys-NexoBrid-for-Emergency-Supply.html
 Bullish
Macroaxis News: globenewswire.com
MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid® Development for the U.S. Army
https://www.globenewswire.com/news-release/2023/09/26/2749330/30505/en/MediWound-Secures-Additional-U-S-Department-of-Defense-Funding-to-Advance-NexoBrid-Development-for-the-U-S-Army.html
 Bullish

Mediwound Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Mediwound and other traded companies coverage with news coverage. We help investors stay connected with Mediwound headlines for the 7th of January to make an informed investment decision based on correlating the impacts of news items on Mediwound Stock performance. Please note that trading solely based on the Mediwound hype is not for everyone as timely availability and quick action are needed to avoid losses.
Mediwound's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Mediwound investors visualize upcoming and past events in order to time the market based on Mediwound noise-free hype analysis.
Mediwound stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Mediwound earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Mediwound that are available to investors today. That information is available publicly through Mediwound media outlets and privately through word of mouth or via Mediwound internal channels. However, regardless of the origin, that massive amount of Mediwound data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Mediwound news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Mediwound relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Mediwound's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Mediwound alpha.

Mediwound Largest EPS Surprises

Earnings surprises can significantly impact Mediwound's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-03-21
2023-12-31-0.23-0.190.0417 
2022-05-17
2022-03-31-0.76-0.84-0.0810 
2021-05-05
2021-03-31-0.78-0.70.0810 
2023-05-30
2023-03-31-0.3-0.44-0.1446 
2022-08-09
2022-06-30-0.68-0.84-0.1623 
2020-11-10
2020-09-30-0.67-0.490.1826 
View All Earnings Estimates

Mediwound Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Mediwound Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
24th of December 2024
Were Keeping An Eye On MediWounds Cash Burn Rate
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
17th of December 2024
MediWound to Host Virtual Key Opinion Leader Event to Discuss Es
at gurufocus.com 
Yahoo News
27th of November 2024
MediWound Third Quarter 2024 Earnings Misses Expectations
at finance.yahoo.com 
Yahoo News
26th of November 2024
MediWound Q3 Earnings Snapshot
at finance.yahoo.com 
seekingalpha News
25th of November 2024
MediWound Q3 2024 Earnings Preview
at seekingalpha.com 
zacks News
13th of November 2024
Durect Reports Q3 Loss, Misses Revenue Estimates
at zacks.com 
zacks News
6th of November 2024
Xencor Reports Q3 Loss, Tops Revenue Estimates
at zacks.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Mediwound in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Mediwound's short interest history, or implied volatility extrapolated from Mediwound options trading.
When determining whether Mediwound is a strong investment it is important to analyze Mediwound's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mediwound's future performance. For an informed investment choice regarding Mediwound Stock, refer to the following important reports:
Check out Mediwound Backtesting and Mediwound Hype Analysis.
For information on how to trade Mediwound Stock refer to our How to Trade Mediwound Stock guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mediwound. If investors know Mediwound will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mediwound listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.91)
Revenue Per Share
2.18
Quarterly Revenue Growth
0.061
Return On Assets
(0.16)
Return On Equity
(0.76)
The market value of Mediwound is measured differently than its book value, which is the value of Mediwound that is recorded on the company's balance sheet. Investors also form their own opinion of Mediwound's value that differs from its market value or its book value, called intrinsic value, which is Mediwound's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mediwound's market value can be influenced by many factors that don't directly affect Mediwound's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mediwound's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mediwound is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mediwound's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.